Shared on04 Aug 25Fair value Decreased 15%
Bora Pharmaceuticals’ consensus price target has been notably reduced, likely reflecting a slight decline in its future P/E ratio while profit margins remain stable, resulting in a revised fair value of NT$813.95. What's in the News Completed share buyback of 36,000 shares (0.26%) for TWD 23.71 million.